查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1969083

脑健康设备市场：全球预测（2026-2032 年），按设备类型、技术、年龄层、应用、最终用户和分销管道划分

Brain Health Device Market by Device Type, Technology, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脑健康设备市场价值将达到 85.9 亿美元，到 2026 年将成长至 96.2 亿美元，到 2032 年将达到 192.5 亿美元，复合年增长率为 12.22%。

主要市场统计数据
基准年 2025 85.9亿美元
预计年份：2026年 96.2亿美元
预测年份 2032 192.5亿美元
复合年增长率 (%) 12.22%

本文探讨了脑部健康设备领域不断演变的格局，其中临床严谨性、消费者期望和技术融合决定了策略挑战。

脑健康设备领域融合了临床神经科学、消费技术和数位治疗方法，形成了一个独特的类别，整合了生理感测、神经调控和软体驱动的认知评估。非侵入性刺激技术的进步、精密的神经回馈系统以及日益先进的可穿戴设备，正在拓展临床路径和日常健康选择。在这种模式下，设备生态系统不再只是一系列独立的产品线，而是一套相互连结的工具网络，为寻求提升认知功能的患者、临床医生、运动员和消费者创造医疗、行为和体验价值。

变革性的技术、监管和行为变化正在推动脑健康设备在临床和商业性应用方面取得新的突破。

脑健康设备领域正受到三大因素的共同影响而重塑：科技的快速成熟、监管要求的不断演变以及临床和消费领域使用者行为的改变。在技​​术层面，感测器精确度的提升、讯号处理技术的进步以及封闭回路型神经调控技术的进步，在扩大临床意义终点范围的同时，也减轻了使用者的负担。这些进步正促使设备从辅助研究工具转变为整合式医疗服务推动者和具有更清晰疗效路径的消费者健康产品。

本研究评估了美国关税趋势在 2025 年将如何造成供应链、定价和策略转变，从而对设备商业化和采购产生重大影响。

美国在2025年实施的关税将对脑健康设备公司产生复杂的营运和策略影响，其影响远不止于直接的成本压力。特别是，关税引发的零件采购变化，例如电子子系统、磁性组件和专用感测器，如果定价策略不进行调整，可能会导致单位製造成本上升和利润率下降。因此，采购团队正在重新评估其供应商基础，探索替代生产地点，并加速双重采购以降低集中采购风险。

针对设备类型、底层技术、临床和消费者应用、使用者环境、通路和人口统计群体进行高解析度細項分析。

稳健的細項分析揭示了产品创新和商业化在设备外形、底层技术、应用领域、终端用户环境、分销管道和年龄组等方面能够带来特别高回报的领域。从装置类型来看，非侵入式神经刺激设备）、专注于认知评估和神经回馈的软体套件，以及将感测器功能与使用者舒适度相结合的穿戴式装置（例如帽子和头带）都蕴藏着不同的机会。能够将硬体人体工学与清晰的软体驱动效能指标结合的公司，可以加速临床应用和消费者渗透。

美洲、欧洲、中东和非洲以及亚太地区的区域采用和商业化趋势决定了差异化的打入市场策略和业务运作。

区域趋势会影响部署时间、报销途径和供应链选择，因此需要製定因地理而异的策略。在美洲，临床网路和私人保险体系促进了实证医疗器材的早期应用，而充满活力的创投生态系统则支援快速的原型到市场转化週期。然而，经济效益论证必须根据区域采购考量和报销差异进行单独调整。在欧洲、中东和非洲，监管协调工作和各国医疗保健模式的差异既带来了挑战也带来了机会，而集中采购倡议和区域卓越中心则影响着医院和研究机构的部署。

竞争定位和能力映射揭示了竞争对手、软体创新者和专业新参与企业如何塑造其差异化和伙伴关係模式。

脑健康设备生态系统内的竞争呈现出多种多样的组织模式，既有拥有整合製造和监管专业知识的成熟医疗设备製造商，也有专注于演算法和使用者体验的软体公司。成熟製造商利用其临床信誉和分销网络推动产品在医院和诊所的应用，而软体和可穿戴设备领域的新兴参与企业则往往优先考虑以消费者为中心的人体工学设计和快速迭代周期，以直接满足消费者的需求。

经营团队が运用リスクを低减し、エビデンス创出を加速させ、责任ある形で脳健康製品を拡大するための実践的かつ段阶的な提言

产业领导者应优先采取切实可行的措施，在保持战略选择权的同时，加速安全且扩充性的部署。首先，应实现采购和製造地的多元化，以降低关税风险和供应中断的影响。这包括建立双重筹资策略，并评估关键零件的近岸外包。其次，应策略性地投资于与预期用途声明和支付方要求相符的临床证据项目，开发结合随机评估和真实世界结果的混合研究设计，以满足监管机构和采购方的需求。

我们采用透明的多方法研究途径，结合专家访谈、技术设备评估和政策分析，提供检验且可操作的见解。

本分析整合了多种研究途径的洞见，强调三角验证和透明度。主要资料来源包括对临床医生、医疗设备工程师、采购专家和监管机构的结构化访谈，并辅以医疗设备架构和软体堆迭的技术审查。政策和关税评估是基于公开的监管文件、海关指南和贸易通告，建构了切合实际的营运场景和风险缓解策略。此调查方法优先考虑对资讯来源进行交叉检验，以减少对单一资讯来源的依赖，并突出一致的策略主题。

脳健康デバイス分野における长期的な成功を、エビデンス・运用上のレジリエンス・伙伴关係がどのように决定づけるかを明确化する、戦略的示唆の简洁な统合

总而言之，脑健康设备产业正从孤立的创新转向整合的医疗保健和健康生态系统，其成功取决于临床证据、使用者体验、供应链韧性和监管准备的综合考量。感测和刺激技术的进步拓宽了介入措施的范围，但要实现永续应用，需要将这些技术与可验证的成果和清晰的营运路径结合。关税趋势和细微的区域监管差异增加了复杂性，因此拥有多元化供应链和灵活商业化策略的企业更具优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 脑健康设备市场：依设备类型划分

  • 非侵入性
  • 软体
    • 认知功能评估
    • 神经回馈系统
  • 穿戴式装置
    • 帽子
    • 头巾

第9章 脳健康デバイス市场：技术别

  • 神经回馈
    • 基于脑电图
    • fNIRS 基线
  • 经颅直流电刺激
    • 多通道
    • 单通道
  • 经颅磁刺激
    • 深部经颅磁刺激
    • 重复经颅磁刺激

第十章 脑健康设备市场：依年龄组别划分

  • 成人版
  • 对于老年人
  • 儿童

第11章 脳健康デバイス市场：用途别

  • 临床
    • 神经病学
    • 精神病学
  • 消费者健康
  • 运动表现

第十二章 脑健康设备市场：依最终用户划分

  • 诊所
  • 家用
  • 医院
  • 研究中心

第13章 脳健康デバイス市场：流通チャネル别

  • 离线
  • 在线的

第14章 脳健康デバイス市场：地域别

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 脑健康设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 脑健康设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国：脑健康设备市场

第十八章 中国：脑健康设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Boston Scientific Corporation
  • InteraXon Inc.
  • LivaNova PLC
  • Medtronic plc
  • Neuroelectrics Barcelona SL
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NeuroSky, Inc.
  • Nevro Corp.
  • Stryker Corporation
Product Code: MRR-1A1A064C05FE

The Brain Health Device Market was valued at USD 8.59 billion in 2025 and is projected to grow to USD 9.62 billion in 2026, with a CAGR of 12.22%, reaching USD 19.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.59 billion
Estimated Year [2026] USD 9.62 billion
Forecast Year [2032] USD 19.25 billion
CAGR (%) 12.22%

Introducing the evolving brain health device landscape where clinical rigor, consumer expectations, and technological convergence define strategic imperatives

The brain health device arena sits at the confluence of clinical neuroscience, consumer technology, and digital therapeutics, creating a distinct category that blends physiological sensing, neuromodulation, and software-driven cognitive assessment. Advances in noninvasive stimulation, refined neurofeedback systems, and increasingly sophisticated wearables have expanded both clinical pathways and everyday wellness choices. This introduction frames the device ecosystem not merely as discrete product lines but as a networked set of tools that generate medical, behavioral, and experiential value for patients, clinicians, athletes, and consumers experimenting with cognitive enhancement.

As stakeholders navigate this evolving space, they confront a layered regulatory environment, accelerating evidence standards, and heightened expectations around data governance and interoperability. Clinicians seek reproducible outcomes and integration with existing care workflows, while consumer channels demand simplicity, comfort, and clear benefit stories. Meanwhile, software platforms aim to convert continuous signal streams into actionable insights without compromising privacy. This combination of technical complexity and market fragmentation creates both friction and opportunity: organizations that can align robust clinical validation with scalable product design will unlock differentiated adoption pathways.

The remainder of this executive summary lays out the shifts, segmentation lenses, regional dynamics, competitive implications, and concrete next steps leaders can deploy to steward innovation responsibly and capture sustainable advantage in brain health device markets.

Transformative technological, regulatory, and behavioral shifts that are driving new clinical and commercial adoption pathways across brain health devices

The landscape for brain health devices is being reshaped by three convergent forces: rapid technological maturation, evolving regulatory expectations, and changing user behavior across clinical and consumer domains. On the technology front, improvements in sensor fidelity, signal processing, and closed-loop neuromodulation are expanding the range of clinically relevant endpoints while reducing user burden. These advances enable devices to move from adjunctive research tools toward integrated care enablers and consumer wellness products with clearer outcome pathways.

Regulatory ecosystems are responding to this progress by raising the bar for clinical evidence and post-market surveillance, prompting manufacturers to invest earlier in robust study designs and real-world performance monitoring. At the same time, reimbursement frameworks and clinical adoption pathways are becoming more closely tied to demonstrated functional impact rather than device attributes alone. Consumer expectations drive a parallel track: users expect privacy-preserving data practices, elegant product experiences, and clear value propositions for nonclinical use cases. These demands catalyze shifts in go-to-market strategies and partnership models between device makers, software vendors, and healthcare providers.

Taken together, these trends force strategic clarity: companies must balance incremental product innovation with systemic investments in evidence generation, regulatory readiness, and ecosystem partnerships if they intend to convert technical capability into lasting clinical and commercial traction.

Evaluating how United States tariff developments through 2025 create supply chain, pricing, and strategic shifts that materially affect device commercialization and sourcing

United States tariff actions through 2025 introduce a complex set of operational and strategic effects for brain health device companies that extend beyond immediate cost pressures. Tariff-induced changes to component sourcing, particularly for electronic subsystems, magnetic assemblies, and specialized sensors, can increase unit manufacturing costs and compress margins if pricing strategies remain unchanged. As a result, procurement teams are reassessing supplier footprints, exploring alternative manufacturing geographies, and accelerating dual-sourcing to reduce concentration risk.

The tariff environment also alters the calculus for vertical integration and regional manufacturing. Some firms are evaluating nearshoring or establishing regional assembly hubs to mitigate tariff exposure and shorten lead times for clinical trial deployments. This shift has implications for capital allocation and timing of product launches, and it often requires renegotiation of distribution agreements and recalibration of inventory strategies. On the demand side, higher landed costs can complicate pricing conversations with payers and hospital procurement departments, particularly where reimbursement is sensitive to device price points.

Beyond direct cost effects, tariffs influence strategic alliances: partnerships with local manufacturers, contract research organizations, and regional distributors become more valuable as they smooth compliance, logistics, and customs challenges. Companies that proactively model scenario-based supply chain impacts, document cost pass-through strategies, and communicate transparently with customers and regulators will be better positioned to sustain market access and preserve commercialization momentum in a tariff-volatile environment.

High-resolution segmentation insights across device types, enabling technologies, clinical and consumer applications, user settings, channels, and demographic cohorts

A robust segmentation lens clarifies where product innovation and commercialization will deliver disproportionate returns across device form factors, enabling technologies, application domains, end-user settings, distribution channels, and age cohorts. When viewed by device type, opportunities diverge between noninvasive hardware such as nerve stimulation devices, software suites focused on cognitive assessment and neurofeedback, and wearables like caps and headbands that blend sensing with user comfort. Companies that align hardware ergonomics with clear software-driven outcome measures can accelerate clinical acceptance and consumer uptake alike.

Technology segmentation reveals differentiation around neurofeedback modalities, transcranial direct current stimulation variants, and transcranial magnetic stimulation formats. Within neurofeedback, EEG-based and fNIRS-based systems offer distinct trade-offs between temporal resolution and spatial specificity, informing use in cognitive training versus targeted rehabilitation. Transcranial direct current stimulation choices between multi-channel and single-channel architectures affect personalization capabilities and regulatory pathways, while deep TMS and repetitive TMS represent varying intensity and clinic-centric deployment models across the magnetic stimulation spectrum.

Application segmentation separates clinical deployments in neurology and psychiatry from consumer wellness and sports performance use cases, each demanding tailored evidence, user experiences, and reimbursement approaches. End users span clinics, home-use patients, hospitals, and research centers, which require differentiated service models and support. Distribution channels bifurcate into offline and online strategies, influencing margins and brand positioning, while age groups-adult, geriatric, and pediatric-necessitate distinct safety, usability, and engagement design features. Synthesis across these segmentation axes guides product roadmaps and targeted go-to-market plays.

Regional adoption and commercialization dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine differentiated go-to-market and operational plays

Regional dynamics shape adoption rhythms, reimbursement pathways, and supply chain choices in ways that require geographically nuanced strategies. In the Americas, clinical networks and private-payer frameworks favor early adoption of evidence-backed devices, while robust venture ecosystems support rapid prototype-to-market cycles; however, regional procurement sensitivities and reimbursement variability demand tailored economic narratives. Across Europe, Middle East & Africa, regulatory harmonization efforts and diverse national healthcare models present both friction and opportunity, with centralized procurement initiatives and regional Centers of Excellence influencing adoption among hospitals and research institutions.

Asia-Pacific markets exhibit a mix of rapid consumer-level embrace of wearables and strategic government investments in healthcare digitization, producing both sizable pilot platforms and highly competitive local manufacturing ecosystems. These geographies differ in their tolerance for direct-to-consumer neuromodulation versus clinic-administered treatments, and local regulatory expectations can accelerate or delay market entry depending on device classification. Cross-region partnerships and targeted clinical collaborations often function as the most effective route to navigate these variations, enabling companies to adapt evidence packages and distribution models while leveraging regional strengths in manufacturing, clinical research, or consumer engagement.

Taken together, a regionally differentiated approach-sensitive to payer structures, regulatory nuance, and consumer behavior-yields more predictable adoption curves and maximizes return on localized commercialization investments.

Competitive positioning and capability mapping that reveal how incumbents, software innovators, and specialized entrants are shaping differentiation and partnership models

Competitive dynamics within the brain health device ecosystem reflect a spectrum of organizational archetypes, ranging from established medical-device incumbents with integrated manufacturing and regulatory expertise to software-first companies that specialize in algorithms and user experience. Incumbent manufacturers often leverage clinical credibility and distribution networks to drive hospital and clinic adoption, while software and wearable entrants frequently prioritize consumer-focused ergonomics and rapid iteration cycles to capture direct-to-consumer demand.

A growing number of venture-backed challengers and research spinouts focus on narrowing clinical niches where novel neuromodulation or sensing approaches can demonstrate clear functional benefits. These players commonly form partnerships with academic centers to accelerate evidence generation and with contract manufacturers to scale production efficiently. Meanwhile, alliances between device firms and digital health platforms are increasing, as vendors integrate longitudinal outcome tracking, remote monitoring, and telehealth-enabled clinical oversight into their offerings to support reimbursement and adherence.

Strategic differentiation increasingly hinges on the ability to generate high-quality clinical data, secure favorable regulatory determinations, and demonstrate real-world impact through deployable service models. Companies that combine technological novelty with operational excellence in manufacturing, distribution, and post-market evidence collection will define the competitive frontier in the coming years.

Actionable, sequenced recommendations for leaders to reduce operational risk, accelerate evidence generation, and scale brain health products responsibly

Industry leaders should prioritize a set of practical actions that accelerate safe, scalable adoption while preserving strategic optionality. First, diversify procurement and manufacturing footprints to reduce tariff and supply disruption exposure; this includes building dual sourcing strategies and assessing nearshoring for critical subassemblies. Second, invest deliberately in clinical evidence programs that align with intended use claims and payer requirements, deploying hybrid study designs that combine randomized evaluations with real-world outcomes to satisfy both regulators and purchasers.

Third, design products and platforms with interoperability and data portability in mind to ease integration with electronic health records and telehealth workflows. Fourth, create clear, age-appropriate user experiences and training materials that address adult, geriatric, and pediatric needs to drive adherence and clinical utility. Fifth, adopt privacy-first data governance and transparent consent frameworks that build trust with clinicians and consumers alike, while preparing for evolving regulatory scrutiny on AI and data-driven claims.

Finally, pursue targeted partnerships with clinical networks, sports performance organizations, and consumer distribution channels to validate use cases and scale deployment. By sequencing these actions-supply chain mitigation, evidence generation, integration readiness, user-centered design, data governance, and strategic partnerships-leaders can convert technical capability into reproducible clinical and commercial outcomes.

Transparent multi-method research approach combining expert interviews, technical device assessment, and policy analysis to deliver validated and actionable insights

This analysis synthesizes findings from a multi-method research approach that emphasizes triangulation and transparency. Primary inputs comprised structured interviews with clinicians, device engineers, procurement specialists, and regulators, supplemented by technical reviews of device architecture and software stacks. Policy and tariff assessments were generated from public regulatory filings, customs guidance, and trade notices to construct plausible operational scenarios and mitigation pathways. The methodology prioritized cross-validation across sources to reduce reliance on single-channel signals and to surface consistent strategic themes.

Secondary research examined peer-reviewed clinical literature, white papers, and conference proceedings to evaluate evidence standards and outcome measures pertinent to device claims. Device usability and ergonomics were assessed through product documentation and, where available, hands-on demonstrations and developer briefings. The analysis acknowledges limitations inherent in rapidly evolving regulatory decisions and in proprietary commercial agreements that are not publicly disclosed; therefore, recommendations emphasize adaptable strategies that remain robust across potential future states.

All conclusions were iteratively reviewed with subject-matter experts to ensure technical accuracy and practical relevance. Where uncertainty exists-particularly around tariff trajectories and national regulatory reforms-scenarios are framed to aid decision-makers in stress-testing strategic choices rather than to provide deterministic forecasts.

Concise synthesis of strategic implications that crystallizes how evidence, operational resilience, and partnerships determine long-term success in brain health devices

In summary, the brain health device sector is transitioning from isolated innovations to integrated care and wellness ecosystems where clinical evidence, user experience, supply resilience, and regulatory readiness jointly determine success. Technological improvements in sensing and stimulation expand the palette of interventions, but durable adoption depends on aligning those capabilities with demonstrable outcomes and clear operational pathways. Tariff dynamics and regional regulatory nuance add layers of complexity that favor organizations with diversified supply chains and flexible commercialization playbooks.

Segmentation analysis highlights where focused investments will pay off: pairing device form factors with the right technology modality and application domain clarifies regulatory demands and commercialization channels. Regionally differentiated strategies unlock adoption advantages by respecting payer structures and deployment norms. Competitive advantage accrues to firms that combine robust clinical programs with scalable manufacturing and thoughtful data governance, enabling them to bridge clinical and consumer markets without sacrificing credibility.

Ultimately, stakeholders who adopt a disciplined, evidence-led commercialization strategy-underpinned by supply chain resilience and partnership-driven market entry-will be best positioned to translate innovation into meaningful clinical and commercial outcomes across the brain health landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Health Device Market, by Device Type

  • 8.1. Noninvasive
  • 8.2. Software
    • 8.2.1. Cognitive Assessment
    • 8.2.2. Neurofeedback System
  • 8.3. Wearable
    • 8.3.1. Cap
    • 8.3.2. Headband

9. Brain Health Device Market, by Technology

  • 9.1. Neurofeedback
    • 9.1.1. EEG Based
    • 9.1.2. fNIRS Based
  • 9.2. Transcranial Direct Current Stimulation
    • 9.2.1. Multi Channel
    • 9.2.2. Single Channel
  • 9.3. Transcranial Magnetic Stimulation
    • 9.3.1. Deep TMS
    • 9.3.2. Repetitive TMS

10. Brain Health Device Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Brain Health Device Market, by Application

  • 11.1. Clinical
    • 11.1.1. Neurology
    • 11.1.2. Psychiatry
  • 11.2. Consumer Wellness
  • 11.3. Sports Performance

12. Brain Health Device Market, by End User

  • 12.1. Clinics
  • 12.2. Home Use
  • 12.3. Hospitals
  • 12.4. Research Centers

13. Brain Health Device Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Brain Health Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Brain Health Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Brain Health Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Brain Health Device Market

18. China Brain Health Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Abbott Laboratories
  • 19.7. Boston Scientific Corporation
  • 19.8. Boston Scientific Corporation
  • 19.9. InteraXon Inc.
  • 19.10. LivaNova PLC
  • 19.11. Medtronic plc
  • 19.12. Neuroelectrics Barcelona S.L.
  • 19.13. NeuroPace, Inc.
  • 19.14. NeuroSigma, Inc.
  • 19.15. NeuroSky, Inc.
  • 19.16. Nevro Corp.
  • 19.17. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN HEALTH DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRAIN HEALTH DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COGNITIVE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COGNITIVE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COGNITIVE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HEADBAND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HEADBAND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HEADBAND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY EEG BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY EEG BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY EEG BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY FNIRS BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY FNIRS BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY FNIRS BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY MULTI CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY MULTI CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY MULTI CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEEP TMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEEP TMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEEP TMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REPETITIVE TMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REPETITIVE TMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REPETITIVE TMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CONSUMER WELLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CONSUMER WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CONSUMER WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SPORTS PERFORMANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SPORTS PERFORMANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SPORTS PERFORMANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 229. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 231. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 234. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 268. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 269. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 273. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 279. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 281. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 283. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 284. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 286. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 310. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)